Veracyte
Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis are available to patients, and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.
Domain
veracyte.com
Country
United StatesIndustry
BiotechnologyEmployees
501-1000
Last Funding
$550.0M
Founded
2005
Tech Stack (26 technologies)
Frequently Asked Questions
What technologies does Veracyte use?+
Veracyte uses 26 technologies including Google Web Toolkit, lit-element, lit-html.
What industry is Veracyte in?+
Veracyte operates in the Biotechnology industry.
Where is Veracyte based?+
Veracyte is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026